Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery

March 26, 2018 | City of Hope

City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.

Leukemia Drug Shows Promise Against Rare Ovarian Cancer

March 2, 2018 | City of Hope

City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.

City of Hope's CAR T Work Gets a Boost from TGen

January 30, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

'Marley Team' seeks to develop early pancreatic cancer screening tools

January 9, 2018 | Stephanie Smith

A multi-institutional partnership, funded in part by a multimillion-dollar grant from the Kemper and Ethyl Marley Foundation, is designed to develop a “mammogram” for pancreatic cancer.

TGen Spotlight: New Study Tackles Sports-Related Concussions

October 16, 2017 | City of Hope

TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection

New Compound Discovered in the Battle Against Brain Cancer

January 30, 2017 | City of Hope

A study led by scientists at the Translational Genomics Research Institute (TGen), a City of Hope affiliate, has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer.

City of Hope's Steven T. Rosen, M.D., on the Impact of the TGen Alliance

December 1, 2016 | City of Hope

In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.

City of Hope Joins Forces with TGen to Bring More Firepower to the Fight Against Cancer

November 30, 2016 | City of Hope

City of Hope is joining forces with the Translational Genomics Research Institute (TGen) to accelerate the speed with which scientists and medical staff can convert research discoveries into cures for patients.